Credit Suisse’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $627K | Hold |
93,492
| – | – | ﹤0.01% | 2527 |
|
|
2023
Q4 | $853K | Buy |
93,492
+19,510
| +26% | +$178K | ﹤0.01% | 2430 |
|
|
2023
Q3 | $408K | Buy |
73,982
+4,457
| +6% | +$24.6K | ﹤0.01% | 2783 |
|
|
2023
Q2 | $594K | Buy |
69,525
+15,136
| +28% | +$129K | ﹤0.01% | 2674 |
|
|
2023
Q1 | $500K | Buy |
54,389
+16
| +0% | +$147 | ﹤0.01% | 2740 |
|
|
2022
Q4 | $555K | Buy |
54,373
+7,258
| +15% | +$74.1K | ﹤0.01% | 2703 |
|
|
2022
Q3 | $694K | Buy |
47,115
+1,604
| +4% | +$23.6K | ﹤0.01% | 2563 |
|
|
2022
Q2 | $489K | Buy |
+45,511
| New | +$489K | ﹤0.01% | 2838 |
|